Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Moodys
Daiichi Sankyo
McKesson
Chinese Patent Office
Chubb
Johnson and Johnson
Boehringer Ingelheim
Cantor Fitzgerald
Baxter
McKinsey

Generated: February 25, 2018

DrugPatentWatch Database Preview

Almotriptan malate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for almotriptan malate and what is the scope of almotriptan malate patent protection?

Almotriptan malate
is the generic ingredient in two branded drugs marketed by Ajanta Pharma Ltd, Mylan Pharms Inc, Teva Pharms Usa, and Janssen Pharms, and is included in four NDAs. Additional information is available in the individual branded drug profile pages.

There are six drug master file entries for almotriptan malate. Six suppliers are listed for this compound.
Summary for almotriptan malate

US Patents and Regulatory Information for almotriptan malate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Janssen Pharms AXERT almotriptan malate TABLET;ORAL 021001-002 May 7, 2001 AB RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Teva Pharms Usa ALMOTRIPTAN MALATE almotriptan malate TABLET;ORAL 078027-002 Jul 7, 2015 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mylan Pharms Inc ALMOTRIPTAN MALATE almotriptan malate TABLET;ORAL 205171-001 Nov 9, 2015 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mylan Pharms Inc ALMOTRIPTAN MALATE almotriptan malate TABLET;ORAL 205171-002 Nov 9, 2015 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Ajanta Pharma Ltd ALMOTRIPTAN MALATE almotriptan malate TABLET;ORAL 205523-002 Mar 3, 2016 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Janssen Pharms AXERT almotriptan malate TABLET;ORAL 021001-001 May 7, 2001 AB RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Teva Pharms Usa ALMOTRIPTAN MALATE almotriptan malate TABLET;ORAL 078027-001 Jul 7, 2015 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Ajanta Pharma Ltd ALMOTRIPTAN MALATE almotriptan malate TABLET;ORAL 205523-001 Mar 3, 2016 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for almotriptan malate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Janssen Pharms AXERT almotriptan malate TABLET;ORAL 021001-001 May 7, 2001 ➤ Sign Up ➤ Sign Up
Janssen Pharms AXERT almotriptan malate TABLET;ORAL 021001-002 May 7, 2001 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Deloitte
Fish and Richardson
Covington
Federal Trade Commission
AstraZeneca
US Department of Justice
Boehringer Ingelheim
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot